Evofem Biosciences Reports Third Quarter 2018 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq rise as chips recover, Broadcom gains on Apple deal
- Oil prices little changed as Saudi cuts prices, OPEC+ boosts target
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Broadcom secures role as key Apple supplier with chip deal through 2031
- Dara Khosrowshahi steps down from Grab Holdings board
- Mahindra & Mahindra Ltd (MM:IN) (MAHMF) PT Raised to INR320 at HSBC
- S&P 500, Nasdaq rise as chips recover, Broadcom gains on Apple deal
Evofem Biosciences (EVFM) Misses Q3 EPS by 34c
November 7, 2018 6:54 AM ESTEvofem Biosciences (NASDAQ: EVFM) reported Q3 EPS of ($0.71), $0.34 worse than the analyst estimate of ($0.37).
"We have made significant progress this quarter in our clinical programs evaluating Amphora for critical areas in women's health where current options are either insufficient or absent entirely," said... More
